Sensitivity and specificity of MGC-NIPS for trisomy 13, trisomy 18, trisomy 21, and sex chromosome aneuploidy screening in 219 Thai pregnant women

Authors

  • Tantip Arigul
  • Wipa Suwannachairob
  • Nasikan Moungklom
  • Verayuth Praphanphoj

DOI:

https://doi.org/10.14456/gag.2020.1

Keywords:

prenatal screening; non-invasive prenatal screening; sensitivity; specificity; semiconductor sequencer

Abstract

Non-invasive prenatal screening (NIPS) has rapidly gained its acceptance as another prenatal screening method in Thailand. It offers higher sensitivity and specificity comparing to the commonly used biochemical tests. We have developed a pipeline called “MGC-NIPS”, based-on chromosome read ratio algorithm, to detect all autosomes and sex chromosome aneuploidy (SCA). Validation on 219 archival data, sequenced by Ion Proton platform, was performed. Over 99% of sensitivity and specificity were achieved for all common autosome and sex chromosome aneuploidy. Two false positive SCA and one false negative Trisomy 18 had occurred. We concluded that MGC-NIPS, using simple chromosome read ratio algorithm on semiconductor sequencer data, is highly accurate. Further prospective study is warranted to gain more confirmative evidence before offering it as an alternative pipeline for NIPS service in Thailand.

References

Alldred SK, Takwoingi Y, Guo B, Pennant M, Deeks JJ, Neilson JP, Alfirevic Z (2017). First trimester ultrasound tests alone or in combination with first trimester serum tests for Down’s syndrome screening. Cochrane Database Syst Rev. 15;3:CD012600.

Gray KJ, Wilkins-Haug LE (2018). Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening. Pediatr Radiol 48:461–470.

Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CWG, Wainscoat JS (1997) Presence of fetal DNA in maternal plasma and serum. 350:485–7.

Grati FR, Malvestiti F, Ferreira JC, Bajaj K, Gaetani E, Agrati C, Grimi B, Dulcetti F, Ruggeri AM, De Toffol S, et al (2014) Fetoplacental mosaicism: Potential mplications for false-positive and false-negative Non-invasive prenatal screening results. Genet Med 16:620–4.

Srebniak MI, Diderich KEM, Noomen P, Dijkman A, de Vries FAT, van Opstal D (2014) Abnormal non-invasive prenatal test results concordant with karyotype of cytotrophoblast but not reflecting abnormal fetal karyotype. Ultrasound Obstet Gynecol 44:109–11.

Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR (2008) Non-invasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 105:16266–71.

Chiu RW, Chan KC, Gao Y, Lau VY, Zheng W, Leung TY, Foo CH, Xie B, Tsui NB, Lun FM, et al (2008) Non-invasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A 105:20458–63.

Norton ME, Brar H, Weiss J, Karimi A, Laurent LC, Caughey AB, Rodriguez MH, Williams J 3rd, Mitchell ME, Adair CD, et al (2012) Non-Invasive Chromosomal Evaluation NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 207: 137.e1–8.

Allyse M, Minear MA, Berson E, Sridhar S, Rote M, Hung A, Chandrasekharan S (2015) Non-invasive prenatal testing: a review of nternational implementation and challenges. Int J Womens Health 7:113–26.

Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Grody WW, et al (2012) DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 14:296–305.

Gregg AR, Skotko BG, Benkendorf JL, Monaghan KG, Bajaj K, Best RG, Klugman S, Watson MS (2016) Non-invasive prenatal screening or fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med 18:1056–65.

Jiang F, Ren J, Chen F, Zhou Y, Xie J, Dan S, Su Y, Xie J, Yin B, Su W, et al (2012) Non-invasive Fetal Trisomy (NIFTY) test: an advanced Non-nvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies. BMC Med Genomics 5:57.

Chen EZ, Chiu RWK, Sun H, Akolekar R, Chan KCA, Leung TY, Jiang P, Zheng YW, Lun FM, Chan LY, et al (2011) Non-invasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma dna sequencing. PLoS One 6:e21791.

Lau TK, Chen F, Pan X, Pooh RK, Jiang F, Li Y, Jiang H, Li X, Chen S, Zhang X (2012) Non-invasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing. J Matern Neonatal Med 25:1370–4.

Straver R, Sistermans EA, Holstege H, Visser A, Oudejans CB, Reinders MJ (2014) WISECONDOR: detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison scheme. Nucleic Acids Res 42:e31.

Chang BC, Chareonsirisuthigul T, Janchompoo P, Srichunrusami C, Pasomsub E, Nasrisuk T, Sensorn I, Panburana P, Chantratita W (2016) Setting Up of First NIPT Service Laboratory in a Thailand Hospital. Next Generat Sequenc & Applic 3:3.

Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754–60.

Scheinin I, Sie D, Bengtsson H, van de Wiel MA, Olshen AB, van Thuijl HF, van Essen HF, Eijk PP, Rustenburg F, Meijer GA, et al (2014) DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly. Genome Res 24:2022–32.

Chiu RW, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, Lun FM, Go AT, Lau ET, To WW, et al (2011) Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 342:c7401.

Kim SK, Hannum G, Geis J, Tynan J, Hogg G, Zhao C, Jensen TJ, Mazloom AR, Oeth P, Ehrich M, et al (2015) Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts. Prenat Diagn 35:810–5.

Taylor-Phillips S, Freeman K, Geppert J, Agbebiyi A, Uthman OA, Madan J, Clarke A, Quenby S, Clarke A (2016) Open accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: A systematic review and meta-analysis. BMJ Open 6:e010002.

Bianchi DW (2018) Cherchez la femme: maternal incidental findings can explain discordant prenatal cell-free DNA sequencing results. Genet Med 20:910–7.

Wilkins-Haug L, Zhang C, Cerveira E, Ryan M, Mil-homens A, Zhu Q, Reddi H, Lee C, Bianchi DW (2018) Biological explanations for discordant Non-invasive prenatal test results: Preliminary data and lessons learned. Prenat Diagn 38:445–58.

Hartwig TS, Ambye L, Sørensen S, Jørgensen FS (2017) Discordant non-invasive prenatal testing (NIPT) - a systematic review. Prenat Diagn 37:527–39.

Wang Y, Chen Y, Tian F, Zhang J, Song Z, Wu Y, Han X, Hu W, Ma D, Cram D, et al (2014) Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. Clin Chem 60:251–9.

Tian Y, Zhang L, Tian W, Gao J, Jia L, Cui S (2018) Analysis of the accuracy of Z-scores of non-invasive prenatal testing for fetal Trisomies 13, 18, and 21 that employs the ion proton semiconductor sequencing platform. Mol Cytogenet 11:49.

Downloads

Published

2020-04-23

Issue

Section

Research Articles